AZTHERAPIES INC has a total of 34 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are ASCENDIS PHARMA GROWTH DISORDERS AS, MORLEY JOHN and VASOGENIX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | Canada | 5 | |
#4 | United States | 5 | |
#5 | China | 4 | |
#6 | Mexico | 3 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Hong Kong | 1 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Elmaleh David R | 19 |
#2 | Franzusoff Alex | 10 |
#3 | Elmaleh David | 9 |
#4 | Gonzalez Juan B | 6 |
#5 | David Elmaleh | 2 |
#6 | Ashton-Rickardt Philip G | 2 |
#7 | David R Elmaleh | 2 |
#8 | Gonzalez Juan | 1 |
#9 | Alex Franzusoff | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020214538A1 | Treatment and prevention of dementia and other neurodegenerative diseases | |
AU2019242381A1 | CAR-Treg-based therapies for treating neurodegenerative diseases | |
AU2017423862A1 | Powdered formulations of cromolyn sodium and ibuprofen | |
CA3005909A1 | Compositions and methods for treating ischemic stroke | |
KR20180081807A | Methods of treating Alzheimer's disease and related disorders | |
AU2014284656A2 | Methods for delivering cromolyn |